loadpatents
name:-0.018275022506714
name:-0.015202045440674
name:-0.0092599391937256
Velaparthi; Upender Patent Filings

Velaparthi; Upender

Patent Applications and Registrations

Patent applications and USPTO patent grants for Velaparthi; Upender.The latest application filed is for "naphthyridinone compounds useful as t cell activators".

Company Profile
9.31.36
  • Velaparthi; Upender - Cheshire CT
  • Velaparthi; Upender - Princeton Junction NJ
  • Velaparthi; Upender - Princeton NJ
  • Velaparthi; Upender - Wallingford CT US
  • Velaparthi; Upender - North Haven CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
TGF-beta inhibitors
Grant 11,352,360 - Kinsella , et al. June 7, 2
2022-06-07
Naphthyridinone Compounds Useful As T Cell Activators
App 20210277004 - Chupak; Louis S. ;   et al.
2021-09-09
Substituted Bicyclic Compounds Useful As T Cell Activators
App 20210188845 - Gentles; Robert G. ;   et al.
2021-06-24
TGF beta receptor antagonists
Grant 10,961,239 - Borzilleri , et al. March 30, 2
2021-03-30
Substituted naphthyridinone compounds useful as T cell activators
Grant 10,954,238 - Velaparthi , et al. March 23, 2
2021-03-23
Substituted Pyridopyrimidinonyl Compounds Useful As T Cell Activators
App 20210061802 - Velaparthi; Upender ;   et al.
2021-03-04
Substituted naphthyridinone compounds useful as T cell activators
Grant 10,669,272 - Velaparthi , et al.
2020-06-02
Substituted Naphthyridinone Compounds Useful As T Cell Activators
App 20200109140 - VELAPARTHI; Upender ;   et al.
2020-04-09
TGF-Beta Inhibitors
App 20200031832 - Kinsella; Todd ;   et al.
2020-01-30
Tgf Beta Receptor Antagonists
App 20190337942 - Borzilleri; Robert M. ;   et al.
2019-11-07
TGF Beta RECEPTOR ANTAGONISTS
App 20190292179 - Borzilleri; Robert M. ;   et al.
2019-09-26
TGF-.beta. inhibitors
Grant 10,287,295 - Kinsella , et al.
2019-05-14
Tgf Beta Receptor Antagonists
App 20180250303 - Borzilleri; Robert M. ;   et al.
2018-09-06
GDF-8 inhibitors
Grant 9,981,944 - Ding , et al. May 29, 2
2018-05-29
TGF-Beta Inhibitors
App 20180127426 - Kinsella; Todd ;   et al.
2018-05-10
Imidazo-pyridazine derivatives as casein kinase 1 .delta./ inhibitors
Grant 9,956,220 - Velaparthi , et al. May 1, 2
2018-05-01
TGF-beta inhibitors
Grant 9,884,868 - Kinsella , et al. February 6, 2
2018-02-06
Imidazo-pyridazine Derivatives As Casein Kinase 1 Delta/epsilon Inhibitors
App 20170137427 - Velaparthi; Upender ;   et al.
2017-05-18
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
Grant 9,598,423 - Velaparthi , et al. March 21, 2
2017-03-21
Substituted imidazoles as casein kinase 1 D/E inhibitors
Grant 9,556,179 - Velaparthi , et al. January 31, 2
2017-01-31
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine Derivatives As Casein Kinase 1 D/e Inhibitors
App 20160311824 - Velaparthi; Upender ;   et al.
2016-10-27
Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors
Grant 9,475,817 - Velaparthi , et al. October 25, 2
2016-10-25
GDF-8 Inhibitors
App 20160264553 - Ding; Pingyu ;   et al.
2016-09-15
TGF-Beta Inhibitors
App 20160257690 - Kinsella; Todd ;   et al.
2016-09-08
Novel Substituted Pyrazolo-piperazines As Casein Kinase 1 D/e Inhibitors
App 20160122358 - Velaparthi; Upender ;   et al.
2016-05-05
Substituted pyrazolo-piperazines as casein kinase 1 .delta./.epsilon. inhibitors
Grant 9,273,058 - Velaparthi , et al. March 1, 2
2016-03-01
Pyrazole Substituted Imidazopyrazines As Casein Kinase 1 D/e Inhibitors
App 20150344480 - Velaparthi; Upender ;   et al.
2015-12-03
Novel Substituted Imidazoles As Casein Kinase 1 D/e Inhibitors
App 20150344481 - Velaparthi; Upender ;   et al.
2015-12-03
Imidazopyridazinyl compounds
Grant 9,145,419 - Velaparthi , et al. September 29, 2
2015-09-29
Novel Substituted Pyrazolo-piperazines As Casein Kinase 1 D/e Inhibitors
App 20150133428 - Velaparthi; Upender ;   et al.
2015-05-14
Substituted Bicyclic Heteroaryl Compounds
App 20150126529 - Velaparthi; Upender ;   et al.
2015-05-07
Sulfonamide compounds useful as CYP17 inhibitors
Grant 8,916,553 - Austin , et al. December 23, 2
2014-12-23
Sulfonamide Compounds Useful As Cyp17 Inhibitors
App 20140148453 - Austin; Joel Francis ;   et al.
2014-05-29
Azaindazole compounds
Grant 8,673,922 - Velaparthi , et al. March 18, 2
2014-03-18
Pyrrolotriazine kinase inhibitors
Grant 8,592,579 - Wittman , et al. November 26, 2
2013-11-26
Azaindazole Compounds
App 20130184254 - Velaparthi; Upender ;   et al.
2013-07-18
Triazine kinase inhibitors
Grant 8,415,340 - Velaparthi , et al. April 9, 2
2013-04-09
Imidazopyridazinyl Compounds
App 20130045980 - Velaparthi; Upender ;   et al.
2013-02-21
Pyrrolotriazine Kinase Inhibitors
App 20120302747 - Wittman; Mark D. ;   et al.
2012-11-29
Pyrrolotriazine kinase inhibitors
Grant 8,212,031 - Velaparthi , et al. July 3, 2
2012-07-03
Intermediate useful in preparing certain pyrrolotriazine compounds and a process for making the intermediate
Grant 8,148,522 - Velaparthi April 3, 2
2012-04-03
Pyrrolotriazine Kinase Inhibitors
App 20110124623 - Wittman; Mark D. ;   et al.
2011-05-26
Intermediate Useful In Preparing Certain Pyrrolotriazine Compounds And A Process For Making The Intermediate
App 20110071288 - Velaparthi; Upender
2011-03-24
Pyrrolotriazine kinase inhibitors
Grant 7,879,855 - Wittman , et al. February 1, 2
2011-02-01
Pyrrolotriazine Kinase Inhibitors
App 20110003821 - Velaparthi; Upender ;   et al.
2011-01-06
Triazine Kinase Inhibitors
App 20100197654 - Velaparthi; Upender ;   et al.
2010-08-05
Pyrrolotriazine Kinase Inhibitors
App 20090239838 - Wittman; Mark D. ;   et al.
2009-09-24
Pyrrolotriazine kinase inhibitors
Grant 7,534,792 - Wittman , et al. May 19, 2
2009-05-19
Tyrosine kinase inhibitors
Grant 7,470,696 - Beaulieu , et al. December 30, 2
2008-12-30
Pyrrolotriazine Kinase Inhibitors
App 20080009497 - Wittman; Mark D. ;   et al.
2008-01-10
Tyrosine kinase inhibitors
Grant 7,232,826 - Velaparthi , et al. June 19, 2
2007-06-19
Novel Tyrosine Kinase Inhibitors
App 20070135443 - Beaulieu; Francis ;   et al.
2007-06-14
Tyrosine kinase inhibitors
Grant 7,223,757 - Wittman , et al. May 29, 2
2007-05-29
Tyrosine kinase inhibitors
Grant 7,189,716 - Beaulieu , et al. March 13, 2
2007-03-13
Tyrosine kinase inhibitors
Grant 7,081,454 - Wittman , et al. July 25, 2
2006-07-25
Novel tyrosine kinase inhibitors
App 20060079518 - Wittman; Mark D. ;   et al.
2006-04-13
Novel tyrosine kinase inhibitors
App 20040180897 - Beaulieu, Francis ;   et al.
2004-09-16
Novel tyrosine kinase inhibitors
App 20040092514 - Velaparthi, Upender ;   et al.
2004-05-13
Novel tyrosine kinase inhibitors
App 20040044203 - Wittman, Mark D. ;   et al.
2004-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed